'Breakthrough' deep brain stimulation device for Parkinson's to make clinical debut
Parkinson's disease patients and advocates are marking Friday as the start of a new era for treatment of the illness as a ...
Major Step Toward a Cure: Scientists Solve Decades-Long Parkinson’s Mystery
WEHI researchers have solved a decades-long mystery by determining the structure of human PINK1, a key protein linked to ...
The Lancet1d
Advances in diagnosis, classification, and management of pain in Parkinson's disease
With over 10 million people affected worldwide, Parkinson's disease is the fastest-growing neurological disorder. More than ...
Hosted on MSN1mon
Parkinson's disease could be treated by FDA-approved cancer drug after major research breakthrough
He added, "Our findings also suggest that targeting this interaction with drugs could significantly slow the progression of Parkinson's disease ... wrote, "The anti-Lag3 antibody was successful ...
pharmaphorum8d
Lundbeck brings third Parkinson's drug into clinic
Denmark’s Lundbeck is bringing a third potential drug for Parkinson’s disease to the clinic – a human antibody that the company hopes will tackle the underlying cause of the condition.
Neuroscience News15d
Long-Term NSAID Use Linked to Lower Dementia Risk
A new study finds that long-term use of non-steroidal anti-inflammatory drugs (NSAIDs) is associated with a lower risk of developing dementia.
PharmiWeb9d
A Brief Introduction to Anti-Tumor APIs, Hypoglycemic APIs, and APIs for Parkinson's Disease
Pioneering Cancer TreatmentAnti-tumor Active Pharmaceutical Ingredients (APIs) are vital in today's medical landscape, addressing one of the most pressing health challenges: cancer. These APIs form ...